Abnova (Taiwan) Corporation (TPE:4133)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
21.75
+0.15 (0.69%)
Apr 29, 2026, 1:30 PM CST
-22.18%
Market Cap 1.32B
Revenue (ttm) 351.30M
Net Income (ttm) -1.14M
Shares Out 60.55M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend 0.11 (0.52%)
Ex-Dividend Date Jun 16, 2025
Volume 70,934
Average Volume 96,924
Open 21.85
Previous Close 21.60
Day's Range 21.55 - 21.85
52-Week Range 21.55 - 35.10
Beta 0.51
RSI 32.85
Earnings Date Apr 2, 2026

About Abnova (Taiwan)

Abnova (Taiwan) Corporation engages in the research, development, manufacturing, and sales of monoclonal and multiclonal antibodies, proteins, medical diagnostic instruments, and testing reagents. The company’s products portfolio includes SARS-CoV/CoV-2, DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, Nano, DNAxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating r... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4133
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.